We are live on ! Find out more
PPBT icon

Purple Biotech

15 hedge funds and large institutions have $306K invested in Purple Biotech in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.5% less ownership

Funds ownership: 8.64% → 8.14% (-0.5%)

21% less funds holding

Funds holding: 19 → 15 (-4)

26% less capital inflows, than outflows

Capital inflows: $107K | Capital outflows: $145K

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

80% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 10

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
15
Holders Change
-4
Holders Change %
-21.05%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
10
Closed
5
Calls
–
Puts
$1​K
Net Calls
-⁠$1​K
Net Calls Change
+$23​K

PPBT Hedge Fund Activity: Q1 2026 in Review

15 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2026, worth a combined $306K — down 40% from $513K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of PPBT and 2 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 2 added.

The largest buyer was SmartHarvest Portfolios, adding an estimated $72.2K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $102K sold.

  • 15 institutional investors held Purple Biotech (PPBT) as of Q1 2026, down from 19 in Q4 2025.
  • Funds reported $306K of Purple Biotech stock for Q1 2026, down 40% quarter-over-quarter.
  • 2 funds opened new Purple Biotech positions in Q1 2026 and 5 closed out, a net change of -3 holders.
  • The largest Purple Biotech buyer in Q1 2026 was SmartHarvest Portfolios, an estimated $72.2K added.
  • The largest Purple Biotech seller in Q1 2026 was Two Sigma Investments, an estimated $102K sold.

Based on aggregated 13F filings for Q1 2026.